Back

Agomir of miRNA-30d - a potential new therapeutic target for prevention of ischemic cardiomyopathy after myocardial infarction?

26 August 2022 (15:15 - 15:55)
Organised by:
Congress Presentation Part of: Ischaemia-mediated cardiac injury: pathomechanisms and potential treatments Ischaemia, Infarction, Cardioprotection ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Professor Michael Lichtenauer

Paracelsus Private Medical University, Salzburg (Austria)

5 More presentations in this session

Presentation thumbnail
Multidimensional immunoimaging to characterize the inflammatory reaction after permanent and temporary coronary artery occlusion in mice
Doctor A. Maier (Freiburg, DE)
Abstract Slides
Presentation thumbnail
Arginase 1 in erythrocytes is a critical modulator of cardioprotective signalling by nitric oxide and soluble guanylyl cyclase
Doctor J. Yang (Stockholm, SE)
Abstract Slides
Presentation thumbnail
A methylation-dependent checkpoint by SETD7 promotes myocardial ischemic injury in mice and men
Mr S. Ambrosini (Schlieren, CH)
Abstract Slides
Presentation thumbnail
S1P lyase inhibition improves post-ischemic cardiac remodeling independently of infarct size via S1P receptor 1
Mr M. Benkhoff (Duesseldorf, DE)
Abstract Slides
Presentation thumbnail
Inhibition of coagulation factor XI attenuates inflammation in myocardial ischemia/reperfusion injury
Miss Q. Luo (Mainz, DE)
Abstract Slides

Access the full session

Session thumbnail
Ischaemia-mediated cardiac injury: pathomechanisms and potential treatments

The Event

Event poster

ESC Congress 2022

26 August 2022 15:15 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources